![Memorial Sloan Kettering Hematologic Oncologist Kylee Maclachlan](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/247326/3x2/maclachlan-kylee_191107_04_1200x800-1.jpg?h=10d202d3)
Kylee Maclachlan, MBBCh, PhD
Myeloma Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Assistant Attending Physician
I am a hematologist and researcher specializing in the care of people with multiple myeloma and related disorders, including smoldering myeloma and monoclonal gammopathy of undetermined significance (MGUS). I work with my colleagues at Memorial Sloan Kettering Cancer Center to identify optimal treatment strategies for people with these conditions. We strive for continuous improvement in both treatment efficacy and quality of life, clear communication, and shared decision-making during each step of a patient’s care journey.
Read more
Smoldering myeloma and MGUS can progress to active myeloma that requires treatment. My research examines the genomic changes that predict which patients with smoldering myeloma and MGUS will experience disease progression and subsequently need myeloma therapy. I aim to improve this prediction so we can treat the right patient at the right time. I also research the genomic features that predict patient response to treatment, as well as the interaction of genomic changes with the immune system, with an overarching goal of using these research insights to personalize treatment to each patient’s individual needs.
Having worked in three countries’ health systems, I have experience in treating patients from different backgrounds. This experience dovetails with my interest in health access and equity; I seek to improve historically underrepresented patients’ access to cutting-edge clinical trials, research, and cancer therapeutics.
A myeloma specialist is a doctor with special training in diagnosing and treating myeloma.
My Specialties
- Multiple Myeloma and Related Disorders
Education
- PhD, University of Melbourne, Australia
- MBBCh, University of Otago, New Zealand
Residencies
- Internal Medicine - Capital and Coast District Health Board, New Zealand (2004-2006)
- Internal Medicine - St. Vincents Health, Australia (2007-2009)
Awards and Honors
- Translational Research Award, International Myeloma Society (IMS) and Paula and Rodger Riney Foundation (2023)
- Multiple Myeloma Research Foundation Fellow Award (2021)
- American Society of Hematology Restart Research Award (2021)
- Royal Australasian College of Physicians Research Establishment Grant (2021, 2020)
- Royal Australasian College of Physicians Travelling Fellowship (2019)
- Haematology Society of Australia and New Zealand New Investigator Award (2018)
- Royal College of Pathologists of Australasia Mike and Carole Ralston Travelling Fellowship (2018)
- Snowdome Foundation Fellowship (2018)
- Haematology Society of Australia and New Zealand / Snowdome Foundation Travel Grant (2018)
- Cancer Therapeutics CRC International Travel Grant (2017)
- Myeloma Foundation of Australia Prize for Clinical Research (2017)
- Leukaemia Foundation of Australia PhD grant (2014-2018)
Fellowships
- Clinical Hematology - Alfred Health and Monash Health (2010-2014)
- Hematologic Pathology - Alfred Health and Monash Health (2010-2014)
- Advanced Oncology - Memorial Sloan Kettering Cancer Center (2020-2021)
- Immuno-oncology - Memorial Sloan Kettering Cancer Center (2021-2022)
Board Certifications
- Internal Medicine - Royal Australasian College of Physicians
- Hematology - Royal Australasian College of Physicians
- Pathology - Royal College of Pathologists of Australasia
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Maclachlan sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Maclachlan’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kylee Maclachlan discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].